معرفی
Pietro Marini is a Lecturer in the School of Medicine, Medical Sciences and Nutrition at the University of Aberdeen, where he contributes significantly to medical education and pharmacological research. He serves as MBChB Year 2 Lead, Gateway to Medicine (G2M) Programme Coordinator, and co-coordinates core courses such as 'The Cell' and 'Introduction to Health and Health Services in the U.K.'
- PhD, Pharmacology, Sapienza University of Rome (2008)
- PG Cert in Learning & Teaching in Higher Education, University of Aberdeen (2017)
- ILM3 Level 3 Award in Leadership and Management (2020)
- Fellow of the Higher Education Academy (FHEA, 2016)
Dr. Marini's research focuses on cannabinoid and opioid receptor pharmacology, particularly their roles in G-protein coupled receptor (GPCR) crosstalk, intracellular calcium signaling, and neurodegenerative disorders such as Alzheimer’s disease. He also investigates orphan receptors like BSR-3 in the context of food intake regulation. His work bridges molecular pharmacology and translational medicine.
The most recent articles reflect a dual focus: (1) cannabinoid pharmacology and Nrf2 signaling in neuroprotection and cancer, and (2) innovations in medical education, particularly widening participation through the G2M program. These trends highlight his commitment to both scientific discovery and inclusive pedagogy.
His scientific awards include:
- Principal’s Teaching Excellence Award (2020)
- Medical Directorate Award (2018)
- HE Innovate Award for Widening Participation (2021)
Dr. Marini actively supervises and mentors students, leads curriculum development, and contributes to national educational initiatives. He is a member of the University Education Committee and Senate, and serves as an External Examiner at the University of Glasgow. He has secured research funding from Friends of Anchor and NHS Grampian. His lab collaborates with leading researchers such as Prof. Roger G. Pertwee and Prof. Raphael Mechoulam. He also contributes to academic service as a journal editor and peer reviewer for numerous pharmacology and neuroscience journals.
